Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III) [NA]
A completed clinical trial (MIRA III) comparing drug-eluting stents versus covered metal stents for malignant biliary obstruction.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer [NA]
Clinical trial update evaluating intraoperative radiotherapy (IORT) followed by concurrent chemoradiation therapy (CCRT) or stereotactic bod…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluated capecitabine plus oxaliplatin in patients with advanced or metastatic pancreatic adenocarcinoma; the study has com…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating erlotinib and gemcitabine with or without panitumumab in metastatic pancreatic cancer has results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery [Phase 2]
A Phase 2 trial evaluated panitumumab in combination with chemotherapy and external-beam radiation therapy for locally advanced pancreatic c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors [NA]
The clinical trial update notes completion of a cognitive-behavioral intervention designed to help cancer survivors manage worry, uncertaint…
-
CLINICAL_TRIALS research · 2017-04-05Clinical Trial Update: Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1) [Phase 2]
A Phase 2 clinical trial evaluating stereotactic body radiation therapy after radical resection in patients with advanced pancreatic cancer;…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating a combination of gemcitabine, bevacizumab, and erlotinib in pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating high-dose vitamin C for advanced pancreatic cancer was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer [Phase 3]
Phase 3 trial completed evaluating nadroparin in patients with lung, pancreatic, or prostate cancer, focusing on venous thrombosis.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 1]
A Phase 1 trial of gemcitabine hydrochloride in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: TMS for the Treatment of Pancreatic Cancer Pain [NA]
This entry reports the completion of a clinical trial evaluating transcranial magnetic stimulation (TMS) for managing pain in pancreatic can…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients [Phase 1, Phase 2]
Phase I/II open-label dose-escalation trial of CPI-613 (devimistat) with gemcitabine in cancer patients; the study is terminated.
-
CLINICAL_TRIALS research · 2017-03-20Clinical Trial Update: Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study [NA]
This completed study evaluates the feasibility and reproducibility of functional MRI for imaging pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study evaluating chemoradiation with gemcitabine in combination with panitumu…
-
CLINICAL_TRIALS research · 2017-03-16Clinical Trial Update: Extended Retroperitoneal Lymphadenectomy and Nerve Plexus Clearance Versus Standard Lymphadenectomy in Pancreaticoduodenectomy [NA]
This clinical trial update describes a study comparing extended retroperitoneal lymphadenectomy with nerve plexus clearance to standard lymp…
-
CLINICAL_TRIALS research · 2017-03-13Clinical Trial Update: The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
This clinical trial update discusses the potential roles of ctDNA, PVT1, and reactive oxygen species in diagnosing and treating gastrointest…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine and erlotinib in metastatic or recurrent pancreatic cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer [Phase 2]
Phase 2 trial evaluating lapatinib plus capecitabine as second-line treatment for pancreatic cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This is a completed Phase 1/2 clinical trial evaluating IPI-926 in combination with gemcitabine for metastatic pancreatic cancer.
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer [Phase 1, Phase 2]
A clinical trial evaluating endoscopic pancreatic duct stenting to relieve obstructive pain in pancreatic cancer patients has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
This completed pilot trial evaluated inter- and intra-treatment organ motion in pancreatic cancer patients using an Active Breathing Control…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 study evaluating the combination of pertuzumab and erlotinib for refractory pancreatic cancer was terminated, with results posted …
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Exercise Intervention Study for Pancreatic Cancer Patients [NA]
A completed clinical trial assessing an exercise intervention for patients with pancreatic cancer, sponsored by the German Cancer Research C…
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: EUS BD vs ERCP TP for Pancreatic Cancer [NA]
A clinical trial comparing endoscopic ultrasound-guided biliary drainage to ERCP-based therapy for pancreatic cancer; the trial status is cu…